| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 1,165,000 | 20 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | 20 Jan 2026 | 1 | $0 | 4 | Chief Executive Officer, Director | 22 Jan 2026, 17:48 |
| TCRX | TScan Therapeutics, Inc. | 12 Jan 2024 | 2 | $0 | 4 | Chief Executive Officer, Director | 11 Feb 2025, 17:52 |
| TCRX | TScan Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Chief Executive Officer, Director | 15 Jun 2023, 18:08 |
| TCRX | TScan Therapeutics, Inc. | 02 Feb 2023 | 1 | $0 | 4 | Chief Scientific and Operations Officer | 06 Feb 2023, 16:16 |
| TCRX | TScan Therapeutics, Inc. | 25 Jul 2022 | 1 | $0 | 4 | Chief Scientific and Operations Officer | 27 Jul 2022, 16:30 |
| TCRX | TScan Therapeutics, Inc. | 18 Jan 2022 | 1 | $0 | 4 | Chief Scientific Officer | 20 Jan 2022, 15:26 |
| TCRX | TScan Therapeutics, Inc. | 20 Sep 2021 | 2 | +$31,097 | 4 | Chief Scientific Officer | 22 Sep 2021, 18:48 |
| TCRX | TScan Therapeutics, Inc. | 15 Jul 2021 | 0 | $0 | 3 | Chief Scientific Officer | 15 Jul 2021, 18:16 |